Jacobo Javier A, Vazquez-Gregorio Rafael, Aristizabal Jorge, Pineda Diego, Cardona-Zorrilla Andres F
Neuro-Oncology, Fundación Centro de Tratamiento e Investigación Sobre Cáncer Luis Carlos Sarmiento Angulo (CTIC), Bogotá, COL.
Neurosurgery, National Institute of Neurology and Neurosurgery, Mexico City, MEX.
Cureus. 2024 Nov 3;16(11):e72926. doi: 10.7759/cureus.72926. eCollection 2024 Nov.
The cornerstone of glioma treatment is the surgical resection of the visible tumor, knowing fully that the disease extends beyond what magnetic resonance imaging (MRI) is able to show and the efficacy of the surgery is highly dependent on the surgeon's expertise. Different intraoperative technologies have emerged to aid in the goal of optimizing the extent of resection for glial tumors. Intraoperative ultrasound (iUS) is an attractive option due to its low cost and real-time imaging. This paper aims to illustrate the utility of this technology as an intraoperative aid for the resection of supratentorial gliomas.
This is an observational and retrospective study that included patients who received surgical resection for supratentorial gliomas using iUS as the only imaging intraoperative aid. Adult patients with supratentorial gliomas who were taken into surgery for tumor resection were included in the analysis. Demographic and clinical variables of the patients at the time of diagnosis were collected, including sex and age. Tumor morphological variables were collected, including the affected lobes, tumor volume, histological and molecular diagnosis, and extent of resection. The IBM SPSS Statistics for Windows, Version 27.0 (Released 2020; IBM Corp., Armonk, New York, United States) was used for the statistical analysis.
A total of 44 patients were included in the analysis. Thirty-six patients (81.8%) had a high-grade glioma as the final diagnosis. The extent of resection achieved was over 90% in 70.5% of the cases. Conclusion: iUS by itself has been proven to be a valuable tool to improve the localization and resection of supratentorial gliomas.
胶质瘤治疗的基石是对可见肿瘤进行手术切除,要充分认识到该疾病的范围超出了磁共振成像(MRI)所能显示的范围,并且手术效果高度依赖于外科医生的专业技能。为了优化胶质肿瘤的切除范围,出现了不同的术中技术。术中超声(iUS)因其成本低和实时成像而成为一个有吸引力的选择。本文旨在阐述该技术作为幕上胶质瘤切除术中辅助手段的效用。
这是一项观察性回顾性研究,纳入了使用iUS作为唯一术中成像辅助手段进行幕上胶质瘤手术切除的患者。分析纳入了因肿瘤切除而接受幕上胶质瘤手术的成年患者。收集了患者诊断时的人口统计学和临床变量,包括性别和年龄。收集了肿瘤形态学变量,包括受累脑叶、肿瘤体积、组织学和分子诊断以及切除范围。使用IBM SPSS Statistics for Windows,版本27.0(2020年发布;IBM公司,美国纽约州阿蒙克)进行统计分析。
共有44例患者纳入分析。最终诊断为高级别胶质瘤的患者有36例(81.8%)。70.5%的病例切除范围达到90%以上。结论:已证明iUS本身是改善幕上胶质瘤定位和切除的有价值工具。